Clinical efficacy and safety of telmisartan 80 mg once daily compared with enalapril 20 mg once daily in patients with mild-to-moderate hypertension: results of a multicentre study

Summary The efficacy and safety of once‐daily telmisartan 80 mg vs. once‐daily enalapril 20 mg in the treatment of essential hypertension were evaluated in a multicentre, single‐blind, placebo‐controlled, randomised trial. In total, 68 patients (49 females, 19 males) with mild‐to‐moderate hypertensi...

Ausführliche Beschreibung